Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenomethionine with Chemoradiation for Stage III NSCLC
NCT00526890Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Oct 2006
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selenomethionine in non-small cell lung cancer (NSCLC), sponsored by Roswell Park Comprehensive Cancer Center. Started Oct 2006; status: terminated.
02
Drugs
selenomethionine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00526890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526890.